Get our Free Patent Expiration Newsletter

Serving leading biopharmaceutical companies globally:

Harvard Business School
McKinsey
Medtronic
Johnson and Johnson
Dow
Boehringer Ingelheim

Last Updated: October 15, 2019

DrugPatentWatch Database Preview

Hospira Inc Company Profile

See Plans and Pricing

« Back to Dashboard

What is the competitive landscape for HOSPIRA INC, and what generic and branded alternatives to HOSPIRA INC drugs are available?

HOSPIRA INC has eighty-six approved drugs.

There are four tentative approvals on HOSPIRA INC drugs.

Summary for Hospira Inc

Drugs and US Patents for Hospira Inc

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Hospira Inc MEROPENEM meropenem INJECTABLE;INJECTION 090940-002 Jun 22, 2010 AP RX No No   See Pricing   See Pricing
Hospira Inc BRETYLIUM TOSYLATE IN DEXTROSE 5% IN PLASTIC CONTAINER bretylium tosylate INJECTABLE;INJECTION 019008-001 Apr 29, 1986 DISCN No No   See Pricing   See Pricing
Hospira Inc CISATRACURIUM BESYLATE cisatracurium besylate INJECTABLE;INJECTION 203236-002 Mar 30, 2018 DISCN No No   See Pricing   See Pricing
Hospira Inc SODIUM BICARBONATE sodium bicarbonate INJECTABLE;INJECTION 202494-002 Mar 6, 2017 AP RX No No   See Pricing   See Pricing
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration
Paragraph IV (Patent) Challenges for HOSPIRA INC drugs
Drugname Dosage Strength Tradename Submissiondate
➤ Subscribe Injection 100 mg/mL, 2.5 mL vials ➤ Subscribe 2007-09-24
➤ Subscribe Injection 1 mg/mL, 50 mL vials ➤ Subscribe 2011-12-16
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

McKinsey
AstraZeneca
Express Scripts
Dow
Colorcon
Moodys

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.